Profil
Josh Jones Dilworth is the founder of Litmus Health, Inc. He is currently the Director at Entrepreneurs Foundation of Central Texas since 2019 and the Venture Partner at NextGen Venture Partners LLC since 2016.
He completed his undergraduate degree at Haverford College in 2002.
Aktive Positionen von Josh Dilworth
| Unternehmen | Position | Beginn |
|---|---|---|
Litmus Health, Inc.
Litmus Health, Inc. Internet Software/ServicesTechnology Services Operates as data science platform for early-stage clinical trials | Gründer | - |
Entrepreneurs Foundation of Central Texas
Entrepreneurs Foundation of Central Texas Miscellaneous Commercial ServicesCommercial Services Operates as civic and social organization | Direktor/Vorstandsmitglied | 01.01.2019 |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Private Equity Investor | 01.01.2016 |
Ausbildung von Josh Dilworth
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Haverford College
Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entrepreneurs Foundation of Central Texas
Entrepreneurs Foundation of Central Texas Miscellaneous Commercial ServicesCommercial Services Operates as civic and social organization | Commercial Services |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Finance |
Litmus Health, Inc.
Litmus Health, Inc. Internet Software/ServicesTechnology Services Operates as data science platform for early-stage clinical trials | Technology Services |
















